Company profile for Lakewood-Amedex

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lakewood-Amedex is a privately held, clinical stage pharmaceutical company developing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins. The rapid bactericidal action of this novel class of antimicrobials has been demonstrated against more than 70 different bacterial strains so far, including many antibiotic-resistant and biofilm forming bacteria. In the growing crisis of multi...
Lakewood-Amedex is a privately held, clinical stage pharmaceutical company developing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins. The rapid bactericidal action of this novel class of antimicrobials has been demonstrated against more than 70 different bacterial strains so far, including many antibiotic-resistant and biofilm forming bacteria. In the growing crisis of multidrug-resistant infections, Lakewood’s clinical development pipeline is focused on addressing the most life-threatening disease indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3030 University Pkwy, Sarasota, FL 34243
Telephone
Telephone
(941) 225-2515
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-to-participate-in-panel-discussion-at-biofloridas-florida-innovation-conference-302602687.html

PR NEWSWIRE
03 Nov 2025

https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-peer-reviewed-publication-demonstrating-potent-antimicrobial-activity-of-bisphosphocin-class-against-resistant-pathogens-302590806.html

PR NEWSWIRE
22 Oct 2025

https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-to-present-at-bioflorida-regional-event-at-the-roskamp-institute-302570354.html

PR NEWSWIRE
30 Sep 2025

https://www.prnewswire.com/news-releases/lakewood-amedex-names-douglas-manion-md-frcp-c-as-chairman-of-the-board-of-directors-302374383.html

PR NEWSWIRE
12 Feb 2025

https://www.prnewswire.com/news-releases/lakewood-amedex-announces-leadership-changes-301973794.html

PR NEWSWIRE
01 Nov 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty